Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05907343 · ClinicalTrials.gov registry record · NA

Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline

A NA study of Mild Cognitive Impairment, sponsored by University of Texas at Austin.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT05907343: Recruiting NA study of Mild Cognitive Impairment, sponsored by University of Texas at Austin.

NCT05907343 is a NA study of Mild Cognitive Impairment that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 180 participants, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05907343, a NA study of Mild Cognitive Impairment, is actively recruiting participants, sponsored by University of Texas at Austin.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical study is to investigate the effectiveness of non-invasive stimulation to enhance cognitive control abilities in cognitively healthy adults and older adults diagnosed with mild cognitive disorder (MCI). The main questions it aims to answer are: * whether it is possible to restore various cognitive functions in older adults diagnosed with MCI by delivering theta burst stimulation (TBS), a form of transcranial magnetic stimulation, and * whether closed-loop TBS is able to induce therapeutic benefits that outperform open-loop TBS. Participants play a cognitive video game while a brain-computer interface (BCI) analyzes their electroencephalogram (EEG) signals and decodes the presence or absence of the contingent negative variation (CNV) potential, a marker of cognitive control. The BCI triggers TBS when its outputs indicate that the participant is not engaged properly in the video game. Researchers will compare the effects of sham, closed-loop, and open-loop TBS using the outcome metrics described below to see how much cognitive restorations is achievable with each stimulation modality.

Primary Outcome

NIH Toolbox - Cognition Battery: A computerized battery assessing multiple cognitive domains. The primary metric for all subtests is the age- and education-adjusted T-score (normative mean = 50, standard deviation = 10). Includes: Dimensional Change Card Sort, Face-Name Associative Memory Test, Flanker Inhibitory Control and Attention Test, Picture Sequence Memory Test, Rey Auditory Verbal Learning Test, Pattern Comparison Processing Speed Test

Conditions Studied

Interventions

  • DEVICE Sham TBS
  • DEVICE Closed-loop TBS
  • DEVICE Open-loop TBS

Study Locations (1)

Texas

  • Health Discovery Building - Austin

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2023-05-31
Est. Completion 2026-12-31
Phase NA
University of Texas at Austin

257 total trials

What NCT05907343 shows while recruiting

NCT05907343 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,270-participant average among 205 other Mild Cognitive Impairment trials with a reported enrollment target (86% lower).

The record links to 1 condition, with Mild Cognitive Impairment appearing as the primary indexed condition, and to 3 interventions - of which Sham TBS is the first listed.

NCT05907343 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05907343 about?

NCT05907343 is a clinical study titled "Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline". The goal of this clinical study is to investigate the effectiveness of non-invasive stimulation to enhance cognitive control abilities in cognitively healthy adults and older adults diagnosed with mild cognitive disorder (MCI). The main questions it aims to answer are: * whether it is possible to r...

What is the current status of trial NCT05907343?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-05-31. Estimated completion is 2026-12-31.

What conditions does trial NCT05907343 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment.

What interventions are being tested in trial NCT05907343?

The interventions under investigation include: Sham TBS (DEVICE), Closed-loop TBS (DEVICE), Open-loop TBS (DEVICE).

Who is sponsoring clinical trial NCT05907343?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05907343 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Cognitive Impairment

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05907343's enrollment target sits among peer trials

180 56th of 205 higher than 148 of 205 other Mild Cognitive Impairment trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Cognitive Impairment trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01558804 · 180 participants

    GRoup A StrePtococcus

  • NCT02932176 · 180 participants

    Machine Learning for Handheld Vascular Studies

  • NCT03384563 · 180 participants · Phase 4

    Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane

  • NCT03423628 · 180 participants · Phase 1

    A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05907343, the US trial registry maintained by the National Library of Medicine. NCT05907343 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.